The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The efficacy of duvelisib monotherapy following disease progression on ofatumumab monotherapy in patients with relapsed/refractory CLL or SLL in the DUO crossover extension study.
 
Bryone J. Kuss
No Relationships to Disclose
 
Matthew Steven Davids
Consulting or Advisory Role - Abbvie; AstraZeneca; Celgene; Genentech; InCyte; Janssen; MEI Pharma; Merck; Pharmacyclics; TG Therapeutics
Research Funding - Abbvie (Inst); Bristol-Myers Squibb (Inst); Genentech (Inst); Infinity Pharmaceuticals (Inst); MEI Pharma (Inst); Pharmacyclics (Inst); Surface Oncology (Inst); TG Therapeutics (Inst)
Travel, Accommodations, Expenses - TG Therapeutics
 
Peter Hillmen
No Relationships to Disclose
 
James H. Essell
No Relationships to Disclose
 
Carol Moreno
No Relationships to Disclose
 
Nicole Lamanna
Consulting or Advisory Role - Abbvie; Celgene; Genentech; Juno Therapeutics; pharmacyclics; ProNAi; Roche
Research Funding - Abbvie (Inst); Genentech/Abbvie (Inst); Gilead Sciences (Inst); Infinity Pharmaceuticals (Inst); ProNAi (Inst)
 
Zsolt Nagy
No Relationships to Disclose
 
Constantine Si Lun Tam
No Relationships to Disclose
 
Stephan Stilgenbauer
No Relationships to Disclose
 
Ulrich Jäger
Honoraria - Abbvie; Amgen; Celgene; Gilead Sciences; Novartis; Roche
Consulting or Advisory Role - Abbvie; Amgen; Celgene; Gilead Sciences; Novartis; Roche
Research Funding - Gilead Sciences (Inst); Novartis (Inst); Roche (Inst)
 
Paolo Ghia
No Relationships to Disclose
 
Julio Delgado
No Relationships to Disclose
 
Ngocdiep T. Le
Employment - Verastem
Leadership - Verastem
Stock and Other Ownership Interests - Verastem
 
Brenda Jeglinski
Employment - Verastem
 
Marco Montillo
No Relationships to Disclose